Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J W Greiner

Showing results (81-90 of 107) with videos related to

Pageof 11
Sort By:
Cancer Research|March 1, 1992
CA 72-4 measurement of tumor-associated glycoprotein 72 (TAG-72) as a serum marker in the management of gastric carcinomaF Guadagni, M Roselli, T Amato, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1996
Systemic administration of recombinant interferon alfa in carcinoma patients upregulates the expression of the carcinoma-associated antigens tumor-associated glycoprotein-72 and carcinoembryonic antigenM Roselli, F Guadagni, O Buonomo, et al.
International Journal of Cancer|April 15, 1989
A monoclonal antibody (D612) with selective reactivity for malignant and normal gastro-intestinal epitheliumR Muraro, M Nuti, P G Natali, et al.
Cancer Investigation|January 1, 1995
CA 72-4 serum marker--a new tool in the management of carcinoma patientsF Guadagni, M Roselli, M Cosimelli, et al.
Medical Oncology and Tumor Pharmacotherapy|January 1, 1991
Monoclonal antibodies in the management of carcinoma patientsM Roselli, C U Casciani, F Guadagni, et al.
Cancer|October 1, 1993
TAG-72 (CA 72-4 assay) as a complementary serum tumor antigen to carcinoembryonic antigen in monitoring patients with colorectal cancerF Guadagni, M Roselli, M Cosimelli, et al.
Cancer|December 1, 1991
Tumor-associated glycoprotein-72 serum levels complement carcinoembryonic antigen levels in monitoring patients with gastrointestinal carcinoma. A longitudinal studyF Guadagni, M Roselli, T Amato, et al.
Cancer Research|August 15, 1988
Generation and characterization of B72.3 second generation monoclonal antibodies reactive with the tumor-associated glycoprotein 72 antigenR Muraro, M Kuroki, D Wunderlich, et al.
Anticancer Research|September 1, 1994
Differential effects of recombinant interferon-alpha and 5-fluorouracil against colon cancer cells or against peripheral blood mononuclear cellsR De Filippi, S P Prete, A Giuliani, et al.
Cancer Research|February 1, 1990
Innovations that influence the pharmacology of monoclonal antibody guided tumor targetingJ Schlom, P H Hand, J W Greiner, et al.
Pageof 11

Showing results (81-90 of 107) with videos related to

Sort By:
Pageof 11
Cancer Research|March 1, 1992
CA 72-4 measurement of tumor-associated glycoprotein 72 (TAG-72) as a serum marker in the management of gastric carcinomaF Guadagni, M Roselli, T Amato, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1996
Systemic administration of recombinant interferon alfa in carcinoma patients upregulates the expression of the carcinoma-associated antigens tumor-associated glycoprotein-72 and carcinoembryonic antigenM Roselli, F Guadagni, O Buonomo, et al.
International Journal of Cancer|April 15, 1989
A monoclonal antibody (D612) with selective reactivity for malignant and normal gastro-intestinal epitheliumR Muraro, M Nuti, P G Natali, et al.
Cancer Investigation|January 1, 1995
CA 72-4 serum marker--a new tool in the management of carcinoma patientsF Guadagni, M Roselli, M Cosimelli, et al.
Medical Oncology and Tumor Pharmacotherapy|January 1, 1991
Monoclonal antibodies in the management of carcinoma patientsM Roselli, C U Casciani, F Guadagni, et al.
Cancer|October 1, 1993
TAG-72 (CA 72-4 assay) as a complementary serum tumor antigen to carcinoembryonic antigen in monitoring patients with colorectal cancerF Guadagni, M Roselli, M Cosimelli, et al.
Cancer|December 1, 1991
Tumor-associated glycoprotein-72 serum levels complement carcinoembryonic antigen levels in monitoring patients with gastrointestinal carcinoma. A longitudinal studyF Guadagni, M Roselli, T Amato, et al.
Cancer Research|August 15, 1988
Generation and characterization of B72.3 second generation monoclonal antibodies reactive with the tumor-associated glycoprotein 72 antigenR Muraro, M Kuroki, D Wunderlich, et al.
Anticancer Research|September 1, 1994
Differential effects of recombinant interferon-alpha and 5-fluorouracil against colon cancer cells or against peripheral blood mononuclear cellsR De Filippi, S P Prete, A Giuliani, et al.
Cancer Research|February 1, 1990
Innovations that influence the pharmacology of monoclonal antibody guided tumor targetingJ Schlom, P H Hand, J W Greiner, et al.
Pageof 11